Go to
JCI Insight
Citations to this article
R O Brady, … , R M Bradley, D Shapiro
Published July 1, 1966
Citation Information: J Clin Invest. 1966;45(7):1112-1115. https://doi.org/10.1172/JCI105417.
Citation Information: J Clin Invest. 1966;45(7):1112-1115. https://doi.org/10.1172/JCI105417.
Abstract
Authors
R O Brady, J N Kanfer, R M Bradley, D Shapiro
Total citations by year
| Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2001 | 2000 | 1999 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1976 | 1975 | 1974 | 1973 | 1972 | 1971 | 1970 | 1969 | 1968 | 1967 | 1966 | 1960 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citations: | 1 | 4 | 4 | 6 | 6 | 9 | 19 | 17 | 9 | 3 | 13 | 5 | 8 | 6 | 11 | 12 | 4 | 2 | 7 | 10 | 7 | 4 | 7 | 3 | 1 | 3 | 3 | 1 | 1 | 3 | 4 | 1 | 4 | 1 | 1 | 3 | 1 | 2 | 4 | 3 | 3 | 1 | 3 | 2 | 5 | 8 | 3 | 8 | 9 | 8 | 9 | 7 | 10 | 7 | 7 | 3 | 1 | 1 | 308 |
Citation information
Citations to this article in year 2019 (19)
| Title and authors | Publication | Year |
|---|---|---|
|
Bioactive Ceramides in Health and Disease: Intertwined Roles of Enigmatic Lipids
J Stiban |
2019 | |
|
Bioactive Ceramides in Health and Disease: Intertwined Roles of Enigmatic Lipids
J Stiban |
2019 | |
|
Bioactive Ceramides in Health and Disease: Intertwined Roles of Enigmatic Lipids
J Stiban |
2019 | |
|
Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish
LT Lelieveld, M Mirzaian, CL Kuo, M Artola, MJ Ferraz, RE Peter, H Akiyama, P Greimel, RJ van den Berg, HS Overkleeft, RG Boot, AH Meijer, JM Aerts |
Journal of lipid research | 2019 |
|
The Effect of Resveratrol on Neurodegenerative Disorders: Possible Protective Actions Against Autophagy, Apoptosis, Inflammation and Oxidative Stress
MH Pourhanifeh, R Shafabakhsh, RJ Reiter, Z Asemi |
Current pharmaceutical design | 2019 |
|
Glycosphingolipids and Infection. Potential New Therapeutic Avenues
JM Aerts, M Artola, M van Eijk, MJ Ferraz, RG Boot |
Frontiers in Cell and Developmental Biology | 2019 |
|
mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cells
RA Brown, A Voit, MP Srikanth, JA Thayer, TJ Kingsbury, MA Jacobson, MM Lipinski, RA Feldman, O Awad |
Disease models & mechanisms | 2019 |
|
In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling
CL Kuo, WW Kallemeijn, LT Lelieveld, M Mirzaian, I Zoutendijk, A Vardi, AH Futerman, AH Meijer, HP Spaink, HS Overkleeft, JM Aerts, M Artola |
The FEBS journal | 2019 |
|
Splenic Artery Aneurysms, A Rare Complication of Type 1 Gaucher Disease: Report of Five Cases
C Serratrice, TM Cox, V Leguy-Seguin, E Morris, K Yousfi, O Monnet, A Sibert, W Allaham, N Belmatoug |
Journal of Clinical Medicine | 2019 |
|
Functionalized cyclophellitols are selective glucocerebrosidase inhibitors and induce a bona fide neuropathic Gaucher model in zebrafish
M Artola, CL Kuo, LT Lelieveld, RJ Rowland, GA van der Marel, JD Codée, RG Boot, GJ Davies, JM Aerts, HS Overkleeft |
Journal of the American Chemical Society | 2019 |
|
Localization of active endogenous and exogenous β‐glucocerebrosidase by correlative light‐electron microscopy in human fibroblasts
E van Meel, E Bos, MJ van der Lienden, HS Overkleeft, SI van Kasteren, AJ Koster, JM Aerts |
Traffic (Copenhagen, Denmark) | 2019 |
|
A case of bony lytic lesions in a patient with Gaucher disease
E McGinnis, HM Razavi |
Clinical Case Reports | 2019 |
|
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
JM Aerts, CL Kuo, LT Lelieveld, DE Boer, MJ van der Lienden, HS Overkleeft, M Artola |
Current Opinion in Chemical Biology | 2019 |
|
Expanding the clinical utility of glucosylsphingosine for Gaucher disease
JT Saville, BK McDermott, SJ Chin, JM Fletcher, M Fuller |
Journal of Inherited Metabolic Disease | 2019 |
|
Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
JS Lee, K Kanai, M Suzuki, WS Kim, HS Yoo, YH Fu, DK Kim, BC Jung, M Choi, KW Oh, Y Li, M Nakatani, T Nakazato, S Sekimoto, M Funayama, H Yoshino, S Kubo, K Nishioka, R Sakai, M Ueyama, H Mochizuki, HJ Lee, SP Sardi, GM Halliday, Y Nagai, PH Lee, N Hattori, SJ Lee |
Brain | 2019 |
|
On the road to unraveling the molecular functions of ether lipids
N JiménezRojo, H Riezman |
FEBS Letters | 2019 |
|
Heat Shock Protein 90 in Human Diseases and Disorders
AA Asea, P Kaur |
2019 | |
|
Novel stereoselective syntheses of N -octyl-β-valienamine (NOV) and N -octyl-4- epi -β-valienamine (NOEV) from (−)-shikimic acid
FL Li, JP Yu, W Ding, MM Sun, YG He, XL Zhu, SL Liu, XX Shi |
RSC Advances | 2019 |
|
Novel stereoselective syntheses of N-octyl-β-valienamine (NOV) and N-octyl-4-epi-β-valienamine (NOEV) from (-)-shikimic acid.
Li FL, Yu JP, Ding W, Sun MM, He YG, Zhu XL, Liu SL, Shi XX |
RSC Advances | 2019 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)